| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.27 | 5e-09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |